share_log
Reuters ·  May 7 07:05
Theriva Biologics Inc -as of March 31, 2024, Theriva Biologics Reports $18.3 Mln in Cash, Which Is Expected to Provide Runway Into Q1 of 2025
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment